Reg 74(5)
Awaiting price reaction for this filing.
Dolphin Medical Services has submitted to BSE a quarterly confirmation certificate from its Registrar and Transfer Agent (RTA), XL Softech Systems Ltd, for the October-December 2025 quarter. The certificate, filed under SEBI's Regulation 74(5), confirms that all share certificates received for dematerialisation during the quarter were properly verified, listed on the stock exchange, mutilated and cancelled, and that the depository names were substituted as registered owners in the company's records within the 30-day window. This is a routine, procedural compliance filing mandated by SEBI for all listed companies. No changes to shareholding, capital structure, or business operations are involved.
This is a standard regulatory compliance submission with no impact on the stock price, shareholding pattern, or the company's fundamentals. Retail investors can safely treat it as routine housekeeping required by SEBI rules.